Determine the necessary mass, volume, or concentration for preparing a solution.
Information
JH-RE-06 JH-RE-06 is a potent REV1-REV7 interface inhibitor with an IC50 of 0.78 μM and Kd value of 0.42 μM, disrupting REV1-POL ζ-mediated mutagenic translesion synthesis (TLS).
Targets
REV1-REV7 (Cell-free assay); REV1-REV7 (Cell-free assay) 0.42 μM(Kd); 0.78 μM
In vitro
JH-RE-06 disrupts mutagenic TLS by preventing recruitment of mutagenic POL ζ. Remarkably, JH-RE-06 targets a nearly featureless surface of REV1 that interacts with the REV7 subunit of POL ζ. Binding of JH-RE-06 induces REV1 dimerization, which blocks the REV1-REV7 interaction and POL ζ recruitment. JH-RE-06 inhibits mutagenic TLS and enhances cisplatin-induced-toxicity in cultured human and mouse cell lines.
In vivo
JH-RE-06 improves tumor cell response to cisplatin in vivo. Co-administration of JH-RE-06 with cisplatin suppresses the growth of xenograft human melanomas in mice, establishing a framework for developing TLS inhibitors as a novel class of chemotherapy adjuvants.
Cell Research(from reference)
Cell lines:HT1080 cells, A375 cells, KP cells, MEF, LNCap cells, AG01522 cells.
Concentrations:1.5 μM
Incubation Time:24 h
| ALogP | 6.232 |
|---|---|
| hba_count | 2 |
| Recuento HBD | 2 |
| Enlace rotable | 6 |
| Sonrisas canónicas | CC(C)CC(=O)C1=C(NC2=CC=C(Cl)C=C2Cl)NC3=C(Cl)C=CC(=C3C1=O)[N+]([O-])=O |
|---|---|
| Peso molecular | 468.72 |
| Reaxy-Rn | 22334922 |
| Reaxys-RN_link_address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=22334922&ln= |
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Fecha | Articulo |
|---|---|---|---|
| Certificate of Analysis | Dec 01, 2023 | J414220 | |
| Certificate of Analysis | Dec 01, 2023 | J414220 | |
| Certificate of Analysis | Dec 01, 2023 | J414220 | |
| Certificate of Analysis | Dec 01, 2023 | J414220 | |
| Certificate of Analysis | Dec 01, 2023 | J414220 | |
| Certificate of Analysis | Dec 01, 2023 | J414220 | |
| Certificate of Analysis | Dec 01, 2023 | J414220 | |
| Certificate of Analysis | Dec 01, 2023 | J414220 | |
| Certificate of Analysis | Dec 01, 2023 | J414220 |
| Solubilidad | Solubility (25°C) In vitro DMSO: 12 mg/mL (25.6 mM); Water: Insoluble; Ethanol: Insoluble; |
|---|---|
| DMSO (mg/ml) Solubilidad máxima | 12 |
| DMSO (mM) Solubilidad máxima | 25.6016385048643 |
| Agua (mg/ml) Solubilidad máxima | <1 |